LONDON (Reuters) - U.S. drugmaker Bristol-Myers Squibb (BMY.N: Quote, Profile, Research) is sounding out potential buyers for a possible sale of its Mead Johnson baby formula food business, which is valued at between $7 billion and $9 billion, the Financial Times said on Monday.
